Find News

Vaccitech, the biotech startup behind AstraZeneca COVID-19 vaccine developed using an altered form of chimpanzee cold virus, tumbles 20% in Nasdaq IPO debut

Vaccitech is an Oxford, U.K.-based biotech startup developing vaccines and immunotherapies for infectious diseases and cancer, such as hepatitis B, HPV, and prostate cancer. Vaccitech owns the technology used to develop the AstraZeneca COVID-19 vaccine. A spinout of Oxford University, Vaccitech […]

The post Vaccitech, the biotech startup behind AstraZeneca COVID-19 vaccine developed using an altered form of chimpanzee cold virus, tumbles 20% in Nasdaq IPO debut appeared first on Tech News | Startups News.

 12 total views

Share this

Leave a Reply

Your email address will not be published. Required fields are marked *

  • Subscribe to our weekly digest to stay in the loop!

    or follow us on our social channels